Profound Medical (PROF) Common Equity (2018 - 2026)

Profound Medical's Common Equity history runs 9 years deep, the most recent figure standing at $59.4 million for Q1 2026.

• In Q1 2026, Common Equity rose 17.0% year-over-year to $59.4 million; the TTM figure through Mar 2026 stood at $59.4 million (up 17.0% YoY), while the FY2025 annual figure was $66.4 million, up 9.95% from the prior year.
• Common Equity was $59.4 million for Q1 2026 at Profound Medical, down from $66.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $66.4 million in Q4 2025 to a low of $30.7 million in Q3 2024.
• Historically, Common Equity has averaged $46.1 million across 5 years, with a median of $45.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Common Equity sank 40.64% in 2023, then soared 93.51% in 2024.
• A 5-year view of Common Equity shows it stood at $52.6 million in 2022, then tumbled by 40.64% to $31.2 million in 2023, then jumped by 93.51% to $60.4 million in 2024, then grew by 9.95% to $66.4 million in 2025, then declined by 10.55% to $59.4 million in 2026.
• The last three Common Equity figures came in at $59.4 million (Q1 2026), $66.4 million (Q4 2025), and $32.1 million (Q3 2025), per Business Quant data.